You have 9 free searches left this month | for more free features.

GSK2140944

Showing 1 - 15 of 15

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Infections, Bacterial Trial in Las Vegas (Gepotidacin, Cimetidine, Rifampicin)

Completed
  • Infections, Bacterial
  • Las Vegas, Nevada
    GSK Investigational Site
Dec 9, 2021

Infections, Bacterial Trial in Miami, Orlando (Gepotidacin)

Completed
  • Infections, Bacterial
  • Miami, Florida
  • +1 more
Mar 17, 2021

Infections, Bacterial Trial in La Mesa (Gepotidacin)

Completed
  • Infections, Bacterial
  • La Mesa, California
    GSK Investigational Site
Jun 12, 2020

Infections, Bacterial Trial in Anaheim, Austin (Gepotidacin RC Tablet, Gepotidacin HSWG Tablet, Gepotidacin Capsule)

Completed
  • Infections, Bacterial
  • Gepotidacin RC Tablet
  • +2 more
  • Anaheim, California
  • +1 more
Sep 14, 2020

Infections, Bacterial Trial in Miami, Orlando, Minneapolis (Gepotidacin)

Completed
  • Infections, Bacterial
  • Miami, Florida
  • +2 more
Jul 13, 2020

Infections, Bacterial Trial in United States (GSK2140944 Lyophile, GSK2140944 Capsules)

Completed
  • Infections, Bacterial
  • GSK2140944 Lyophile
  • GSK2140944 Capsules
  • Phoenix, Arizona
  • +29 more
Oct 16, 2017

Infections, Respiratory Tract Trial in Austin (GSK2140944, GSK2140944 , Moxifloxacin)

Completed
  • Infections, Respiratory Tract
  • GSK2140944
  • +3 more
  • Austin, Texas
    GSK Investigational Site
Jul 10, 2017

Infections, Bacterial Trial in Overland Park (GSK2140944 capsule, GSK2140944 tablet, Itraconazole capsule)

Completed
  • Infections, Bacterial
  • GSK2140944 capsule
  • +2 more
  • Overland Park, Kansas
    GSK Investigational Site
Jul 10, 2017

Infections, Respiratory Tract Trial in London (GSK2140944 for Injection, GSK2140944 Capsule)

Completed
  • Infections, Respiratory Tract
  • GSK2140944 for Injection
  • GSK2140944 Capsule
  • London, United Kingdom
    GSK Investigational Site
Jul 10, 2017

Infections, Respiratory Tract Trial in Minneapolis (GSK2140944, Placebo)

Completed
  • Infections, Respiratory Tract
  • GSK2140944
  • Placebo
  • Minneapolis, Minnesota
    GSK Investigational Site
Jun 9, 2017

Infections, Bacterial Trial in Baltimore (GSK2140944 (Single dose), GSK2140944 (Multiple dose))

Completed
  • Infections, Bacterial
  • GSK2140944 (Single dose)
  • GSK2140944 (Multiple dose)
  • Baltimore, Maryland
    GSK Investigational Site
May 12, 2017

Infections, Respiratory Tract Trial in Overland Park (GSK2140944, Placebo)

Completed
  • Infections, Respiratory Tract
  • GSK2140944
  • Placebo
  • Overland Park, Kansas
    GSK Investigational Site
May 5, 2017

Infections, Respiratory Tract Trial in Randwick (Part A: GSK2140944 Drug single dose of 200mg, 600mg, 1200mg, 1800 mg, and dose

Completed
  • Infections, Respiratory Tract
  • Part A: GSK2140944 Drug single dose of 200mg, 600mg, 1200mg, 1800 mg, and dose to be determined
  • Part B: GSK2140944 Repeat Drug dose of 400mg, 750mg, 1000 mg, and dose to be determined
  • Randwick, New South Wales, Australia
    GSK Investigational Site
May 5, 2017

Gonorrhea Trial in Puerto Rico, United Kingdom, United States (GSK2140944)

Completed
  • Gonorrhea
  • GSK2140944
  • Fountain Valley, California
  • +13 more
Apr 17, 2017

Infections, Bacterial Trial in Las Vegas (Gepotidacin, Placebo)

Completed
  • Infections, Bacterial
  • Las Vegas, Nevada
    GSK Investigational Site
Aug 18, 2020